Medtronic acquired the pump as part of its $1.1 billion acquisition of HeartWare International in 2016. The device helps patients suffering from heart failure pump blood through their bodies. The ...

Medtronic's HeartWare HVAD pump system has been hit with a slew of recalls in recent months and the rate of device malfunction reports documented since it's been on the market in an FDA database ...

Pump thrombosis may develop in patients who are implanted with Medtronic’s HeartWare Ventricular Assist Device (HVAD) system due to a weld defect that has been found in some of the pumps, the US Food ...

A year after pulling its HeartWare Ventricular Assist Device (HVAD) System from the market, Medtronic is still dealing with regulatory issues associated with the device. In a recent update, FDA called ...

The FDA has classified Medtronic’s recall of its HeartWare HVAD ventricular assist devices as Class I, the most serious type, Medtech Dive reported. The HeartWare HVAD ventricular assist devices were ...

After three strikes in just the last six months, Medtronic’s implantable heart pump is out. The company issued (PDF) an urgent message Thursday notifying doctors and patients that it would immediately ...

Five years after Medtronic's billion-dollar purchase of HeartWare International, the company discontinued the device at the center of acquisition — a miniaturized, implantable heart pump — with no ...

Medtronic is recalling its HeartWare ventricular assist device (HVAD) Pump Outflow Graft and Outflow Graft Strain Relief because the outflow graft may tear and the strain relief screw may break during ...